Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville, FL 32224, USA.
J Cell Biol. 2013 Aug 5;202(3):563-77. doi: 10.1083/jcb.201301001.
In response to inflammation, pancreatic acinar cells can undergo acinar-to-ductal metaplasia (ADM), a reprogramming event that induces transdifferentiation to a ductlike phenotype and, in the context of additional oncogenic stimulation, contributes to development of pancreatic cancer. The signaling mechanisms underlying pancreatitis-inducing ADM are largely undefined. Our results provide evidence that macrophages infiltrating the pancreas drive this transdifferentiation process. We identify the macrophage-secreted inflammatory cytokines RANTES and tumor necrosis factor α (TNF) as mediators of such signaling. Both RANTES and TNF induce ADM through activation of nuclear factor κB and its target genes involved in regulating survival, proliferation, and degradation of extracellular matrix. In particular, we identify matrix metalloproteinases (MMPs) as targets that drive ADM and provide in vivo data suggesting that MMP inhibitors may be efficiently applied to block pancreatitis-induced ADM in therapy.
针对炎症,胰腺腺泡细胞可以发生腺泡到导管的转分化(ADM),这是一种重编程事件,可诱导向导管样表型的转化,并且在额外致癌刺激的情况下,有助于胰腺癌的发展。诱导胰腺炎的 ADM 的信号机制在很大程度上尚未确定。我们的结果提供了证据,表明浸润胰腺的巨噬细胞驱动这种转分化过程。我们确定巨噬细胞分泌的炎症细胞因子 RANTES 和肿瘤坏死因子 α(TNF)作为这种信号的介质。RANTES 和 TNF 都通过激活核因子 κB 及其参与调节细胞外基质存活、增殖和降解的靶基因诱导 ADM。特别是,我们确定基质金属蛋白酶(MMPs)作为驱动 ADM 的靶标,并提供体内数据表明,基质金属蛋白酶抑制剂可能有效地用于在治疗中阻断胰腺炎诱导的 ADM。